Joplin Globe4d
McDonald’s USA, Syngenta and Lopez Foods Collaborate to Help Produce Beef More Sustainably in the US
“At Syngenta, we’re convinced improving the sustainability of the global food system can be accelerated through innovation ...
Matson downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research downgraded Matson (MATX) to Peer Perform from Outperform. The firm cites valuation for the downgrade. Matson has materially ...
Veracyte initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target Published first on TheFly – the ...
Hosted on MSN1d
Wolfe Research Downgrades Matson (MATX)
Fintel reports that on November 18, 2024, Wolfe Research downgraded their outlook for Matson (NYSE:MATX) from Outperform to ...
Investing4d
Wolfe Research sets stock target on Veracyte, cites growth potential
On Friday, Wolfe Research initiated coverage on shares of Veracyte, Inc (NASDAQ:VCYT), a diagnostics company, with an Outperform rating and a price target of $50.00. The firm highlighted Veracyte ...
Fintel on MSN3d
Wolfe Research Initiates Coverage of Gilead Sciences (GILD) with Outperform Recommendation
Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Gilead Sciences (NasdaqGS:GILD) with a ...
bovnews12h
Why Did Wolfe Research Give Gilead Sciences, Inc. (GILD) Stock Outperform Rating?
On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $88.4 which represents a decrease of $-3.71 or -4.03% from the prior close of $92.11. The stock opened at $91.71 and ...
Amgen (NASDAQ:AMGN) Research Coverage Started at Wolfe Research
Wolfe Research started coverage on shares of Amgen (NASDAQ:AMGN – Free Report) in a report published on Friday, MarketBeat reports. The brokerage issued a peer perform rating on the medical research ...
Nasdaq4d
Wolfe Research starts Amgen at Peer Perform given approaching patent cliffs
Wolfe Research analyst Alexandria Hammond initiated coverage of Amgen (AMGN) with a Peer Perform rating. With the antibody backbone, the firm is acknowledges the potential for differentiation for ...
Investing3d
Wolfe Research sets stock target on Veracyte, cites growth potential
On Friday, Wolfe Research initiated coverage on shares of Veracyte, Inc (NASDAQ:VCYT), a diagnostics company, with an Outperform rating and a price target of $50.00. The firm highlighted Veracyte's ...
Nasdaq4d
Wolfe Research starts BioMarin at Outperform given its blockbuster with Voxzogo
Wolfe Research initiated coverage of BioMarin (BMRN) with an Outperform rating and $95 price target With limited downside risk following recent share pullback, a new management team, and robust ...
Investing4d
Wolfe Research initiates Repligen shares coverage with Peerperform rating
On Thursday, Wolfe Research began coverage on shares of Repligen (NASDAQ:RGEN) Corporation (NASDAQ:RGEN), a leading bioprocessing company, with a Peerperform rating. The firm highlighted Repligen ...